Literatur
Schultz KAP, Rednam SP, Kamihara J, Doros L, Achatz MI, Wasserman JD et al (2017) PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin. Cancer Res 23(12):e76–e82
Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC et al (2017) Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin. Cancer Res 23(11):e38–e45
Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA et al (2017) Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. Jama Oncol 3(12):1634–1639
Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17(9):1295–1305
Aravanis AM, Lee M, Klausner RD (2017) Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection. Cell 168(4):571–574
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M.G. Sauer gibt an, dass kein Interessenkonflikt besteht.
Additional information
Originalpublikation
Wang Z, Wilson CL, Easton J, Thrasher A et al (2018) Genetic risk for subsequent neoplasms among long-term survivors of childhood cancer. J Clin Oncol 36(20):2078–87
Rights and permissions
About this article
Cite this article
Sauer, M.G. Genetische Risikofaktoren für ein Zweitmalignom bei Kindern nach einer ersten onkologischen Erkrankung . Strahlenther Onkol 195, 186–187 (2019). https://doi.org/10.1007/s00066-018-1409-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-018-1409-9